BioCorRx (BICX) Enterprise Value (2016 - 2025)
Historic Enterprise Value for BioCorRx (BICX) over the last 17 years, with Q3 2025 value amounting to $432656.0.
- BioCorRx's Enterprise Value rose 35171.39% to $432656.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $432656.0, marking a year-over-year increase of 35171.39%. This contributed to the annual value of -$322845.0 for FY2024, which is 6636.69% down from last year.
- As of Q3 2025, BioCorRx's Enterprise Value stood at $432656.0, which was up 35171.39% from -$500899.0 recorded in Q2 2025.
- BioCorRx's Enterprise Value's 5-year high stood at $432656.0 during Q3 2025, with a 5-year trough of -$2.0 million in Q1 2021.
- For the 5-year period, BioCorRx's Enterprise Value averaged around -$379264.9, with its median value being -$269311.0 (2025).
- Examining YoY changes over the last 5 years, BioCorRx's Enterprise Value showed a top increase of 35171.39% in 2025 and a maximum decrease of 22413.09% in 2025.
- Over the past 5 years, BioCorRx's Enterprise Value (Quarter) stood at -$203676.0 in 2021, then increased by 4.81% to -$193872.0 in 2022, then dropped by 0.09% to -$194056.0 in 2023, then tumbled by 66.37% to -$322845.0 in 2024, then soared by 234.01% to $432656.0 in 2025.
- Its last three reported values are $432656.0 in Q3 2025, -$500899.0 for Q2 2025, and -$269311.0 during Q1 2025.